Internal Medicine
Genomic evidence for reinfection with SARS-CoV-2: A case study
14 Oct, 2020 | 09:39h | UTCGenomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases
Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME
Related: Dutch woman dies after catching Covid-19 twice, the first reported reinfection death – CNN
Updated NIH COVID-19 Treatment Guidelines
14 Oct, 2020 | 09:41h | UTCCoronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
See also: What’s New in the Guidelines
COVID-19 and cancer: Current challenges and perspectives
14 Oct, 2020 | 09:35h | UTCCOVID-19 and Cancer: Current Challenges and Perspectives – Cancer Cell
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
14 Oct, 2020 | 09:31h | UTCJohnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT
News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – Health Policy Watch AND Johnson & Johnson pauses Covid-19 vaccine trial after ‘unexplained illness’ – CNN
Non-respiratory presentations of COVID-19, a clinical review
14 Oct, 2020 | 09:33h | UTC
Monoclonal antibody trial halted for safety concern
14 Oct, 2020 | 09:30h | UTCMonoclonal Antibody Trial Halted for Safety Concern – Brief19
COVID-19 will probably become endemic – here’s what that means
14 Oct, 2020 | 09:27h | UTCCOVID-19 will probably become endemic – here’s what that means – The Conversation
Case report: Sudden irreversible hearing loss post COVID-19
14 Oct, 2020 | 09:24h | UTCSudden irreversible hearing loss post COVID-19 – BMJ Case Reports
Commentaries: Coronavirus: Patient has sudden permanent hearing loss – BBC AND First reported UK case of sudden permanent hearing loss linked to COVID-19 – BMJ
Commentary on Twitter
Sudden hearing loss after #COVID19.
Report of 1st UK case and review of the other 4 published reports (must be *extremely rare*)https://t.co/wCkrgHcwKH pic.twitter.com/onQxxYiImb— Eric Topol (@EricTopol) October 13, 2020
Meta-analysis: Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension
14 Oct, 2020 | 09:20h | UTC
Commentary on Twitter
Which lifestyle intervention works best for hypertension? #Bayesian meta-analysis suggests the #DASH diet https://t.co/1CgLVwN4LB #AHAJournals @tinauchojo pic.twitter.com/wzJ87OPT0m
— JAHA (@JAHA_AHA) October 5, 2020
Meta-analysis: Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery
14 Oct, 2020 | 09:16h | UTCOverall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
In an analysis of 23 randomized trials comparing CABG and PCI, PCI was associated with higher rates of cardiac, non-cardiac, and all-cause mortality. All-cause mortality should be used as endpoint in revascularization trials https://t.co/DBSvVkr3EK
— JAMA Internal Medicine (@JAMAInternalMed) October 12, 2020
Meta-analysis: Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness
14 Oct, 2020 | 09:18h | UTCEditorial: Palliative Care for Patients With Noncancer Illnesses
Commentary on Twitter
In this meta-analysis of RCTs of patients with primarily noncancer illness (mostly heart failure) palliative care was associated w less acute health care use & lower symptom burden, with no difference in quality of life https://t.co/ZtH6w48vz4 @kieranlquinn
— JAMA (@JAMA_current) October 13, 2020
Opinion piece by Dr. John P.A. Ioannidis: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
13 Oct, 2020 | 01:15h | UTC
Pursuing COVID ‘herd immunity’ without a vaccine could be dangerous & unethical, WHO warns
13 Oct, 2020 | 01:16h | UTC
Review: Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19
13 Oct, 2020 | 01:12h | UTC
[Preprint] Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
13 Oct, 2020 | 01:08h | UTC
Commentary on Twitter
Anyone think we prescribe too many #antibiotics in #COVID19?
Looking for ways to prescribe less?
Well, our latest *PREPRINT* (not peer reviewed!) may be of interest. #antibioticstewardship https://t.co/qUimnZhwg7 Thread (1/7) pic.twitter.com/Z6gaGMgduv— Gabriele Pollara (@gpollara) October 12, 2020
‘Long Covid’: Why are some people not recovering?
13 Oct, 2020 | 01:03h | UTC‘Long Covid’: Why are some people not recovering? – BBC
Cohort study: ‘COVID-19 free’ hospital areas linked to improved outcomes in elective cancer surgery
12 Oct, 2020 | 00:48h | UTCCommentary: ‘COVID-19 free’ hospital areas could save lives after surgery, global study finds – University of Birmingham
Study: Three quarters of people with SARS-CoV-2 infection were asymptomatic the day they took the test
12 Oct, 2020 | 00:46h | UTCCommentaries: Covid: more than 80% of positive UK cases in study had no core symptoms – The Guardian AND Symptoms of COVID-19 are a poor marker of infection, new UK population study shows – Taylor & Francis Group AND Expert reaction to analysis of asymptomatic SARS-CoV-2 infection from English Household Survey data – Science Media Centre
Review: Characteristics of SARS-CoV-2 and COVID-19
12 Oct, 2020 | 00:49h | UTCCharacteristics of SARS-CoV-2 and COVID-19 – Nature Reviews Microbiology
Commentary on Twitter
Characteristics of SARS-CoV-2 and COVID-19
Zheng-Li Shi et al. summarize the exceptional amount of research that has characterized SARS-CoV-2 and COVID-19, discussing the emergence and virology of SARS-CoV-2 and the pathogenesis and treatment of COVID-19https://t.co/kGL6nOdOYu pic.twitter.com/1ePqHvLxFz
— Nature Reviews Microbiology (@NatureRevMicro) October 6, 2020
Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset
12 Oct, 2020 | 00:44h | UTCCommentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg
Commentary on Twitter
Follow-up of adults with non-critical COVID-19 two months after symptoms' onset – Clinical Microbiology and Infection Two thirds of adults with non-critical COVID-19 had persistent symptoms up to 2 months after symptom onset. https://t.co/xZk2DURyTG
— Carlos del Rio (@CarlosdelRio7) October 10, 2020
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
12 Oct, 2020 | 00:34h | UTC
Commentary on Twitter
DecubICUs study results: pressure injuries common in adult #ICU: 59.2% ICU-acquired, prevalence 16.2%.
Optimal care standards, increased awareness, proper resource allocation, focused research pivotal to tackle this main #ptsafety threat @StijnBLOT @ESICM https://t.co/gfJ9x06dnB pic.twitter.com/bUeOVwoVxk— Intensive Care Medicine (@yourICM) October 9, 2020
Esophageal emergencies: Another important cause of acute chest pain
12 Oct, 2020 | 00:30h | UTCEsophageal emergencies: another important cause of acute chest pain – Insights into Imaging
RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19
9 Oct, 2020 | 09:15h | UTC
Less is more: Critically ill status is not a carte blanche for unlimited antibiotic use
12 Oct, 2020 | 00:32h | UTC
AHA Scientific Statement: Assessing and addressing cardiovascular health in LGBTQ adults
12 Oct, 2020 | 00:29h | UTCNews Release: Discrimination contributes to poorer heart health for LGBTQ adults – American Heart Association
Commentary: Improving the Cardiovascular Health of the LGBTQ Community: An Urgent Call to Action
Top Things to Know: Assessing and Addressing Cardiovascular Health in LGBTQ Adults


